2nd Quarter - Report

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 946/ S 1862 ORPHAN Cures Act S 832 Ensuring Pathways to Innovative Cures (EPIC) Act HR 1262/ S 932 Give Kids a Chance Act HR 1672 Maintaining Investments in New Innovation Act S 705 Innovation in Pediatric Drugs Act

LobbyistCovered position, as disclosed
SUSANNA AGUIRRE HASTINGS —
CATE MCCANLESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 946 (119th), H.R. 1262 (119th), H.R. 1672 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.